Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate)
Richter
B
B
Department of Metabolic Diseases and Nutrition (WHO Collaborating Centre for Diabetes), Heinrich-Heine University, Düsseldorf, Germany.
Berger
M
M
D003327:Coronary Disease / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D011785:Quality Assurance, Health Care; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D016896:Treatment Outcome
D007004:Hypoglycemic Agents